Cargando...
Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
BACKGROUND: Neuromyelitis optica (NMO) is an inflammatory demyelinating central nervous system disease, with recurrent attacks of severe bilateral optic neuritis and longitudinally extensive transverse myelitis. Aggressive immunosuppression is essential to prevent clinical relapses and permanent dis...
Gardado en:
| Publicado en: | Ann Indian Acad Neurol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5586117/ https://ncbi.nlm.nih.gov/pubmed/28904454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aian.AIAN_499_16 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|